A Study to Evaluate the Safety and Antiviral Activity of Two Human Monoclonal Antibodies (VRC07-523LS and PGT121.414.LS) During Analytic Treatment Interruption in Participants Living With HIV Who Initiated ART During Acute/Early HIV-1 Infection
Clinical trial NCT06987318 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06987318
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2026-12-01
- Primary completion
- 2027-08-29
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.